2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
US7427610B2 · kind B2 · utility
6Cited by
3References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2004 |
| Grant date | Sep 23, 2008 |
| Priority date | — |
| Expiry date | Feb 19, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J41/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of formula Iand use thereof in a method of treating a tumor disease that can be influenced positively by the inhibition of tubulin polymerization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.